Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
We are not pumping , we just believing !!! And not crying !!! Like I said before - we will see who is who very soon . So, all your predictions , negativity's now - just guessing EMPTY WORDS !!!
We will see very soon who is who & who is Fool , now just morning , but you already unhappy , negative mood like usually.....p.s. everyone who is not agree with your negative prediction in this board , you call - idiots & fools . Look yourself in mirror & clean up your tongue first...................Have nice good day !!!
Nobody knows ............ all of your problems , you & Shawn's negative friends don't believe in Miracles , you guys are too much realistic .... but we are Optimistic......
Nice prediction from Yahoo board (SoCalDreamer72) : Hello everyone. With all the talk and speculation I figured I would take a stab at predicting INNV's
future pps. Instead of guessing, I looked at other Pharma companies and compared their numbers.
Yes, they are profitable, so will INNV be soon.
.
Celg $124 pps 774,000,000 shares MC 95.6 bill
Yearly rev. 11.229 billion
Pfizer. $33.88 pps. 5.9 billion shares MC 202b. Yearly revenue. 52.8 billion
Gsk $40.9 pps. 420,912,000 shares MC101.6 b
Yearly rev 27.8 billion
CELG revenue is 11.5% of market cap
Pfizers revenue is 26% of market cap
GSK. Revenue is 27% of market cap
This is a small sample, but I will toss CELG out as an outlier for the first number. This means that the average percentage of rev to market cap is 26.5%.
If INNV follows this same model then it will have 75 mill in revenues as stated earlier on this board. If that is 26.5% of market cap as per model then market cap should be 283 million. Dividing 283 million by os pps would be $2.28. That is figured by dividing market cap $283 million by os 124.8 million (per innv website.)
If using CELG as a model it would be $652 million mc and pps of $5.25.
I feel we have good times ahead. p.s. Its better then listen cry from Shawn .............
SHAWN - you said ( then you're an idiot) Who give to you permission call people - IDIOT ? you who has bunch of shares , who miss few time run , who cry like baby every morning ,if not trust INNV just leave wit loss, be man , but you still hope you will get your 0.40+ c. .... I'm not going to call you - Idiot , you just unhappy person .
Swawn - What are you talking ? R/S with this price ? it is joke ... price for R/S need be at least 0.40-0.60c. for get his target to Nasdaq ...talking , talking , talking about nothing , just morning but you already negative , look outside sunny morning !!! p.s. and R/S MAYBE , MAYBE ...... until he said R/S , your prediction EMPTY WORD !!!
This is 4 YEARS old article , your point ? or it is just voice of loser >>>>>>>>>>>>>>>>>>
( Dumb of Damaj/INNV, to over promise and undeliver! I bet you that INNV fails to meet, Q1 Q2 Q3 for 2017 and even if it missed by a small amount, the fact that it missed will F the share price even more.
Damaj, ya dumb fool! Learn to under promise and over delivery, or at least be realistic!) !!!!!!!!!!!!????? Voice of BIG UPSAD LOSER , WHO STILL KEEP POSITION , BUT STARTED PANIC ...........
200K shares - bid , no trade almost 2 hours ,last trade was 12.12pm. something cooking .......
You guys- just paying on guessing , during stock has negative comments...............
Androck - Q? so, what are you doing here ? Try to save our $$$ ? but its to late , What is your interest here? spend everyday in this message board ,, with losers,, .... Last 19 years I saw some people like you & your team , and its true ,your negative strategy is working , but temporary working , for weak hands.
Very soon we will see who is who.....
Adrock - just paying on guessing , during stock has negative comments , missing 2016 number is joke $190K , but MM used this panic miss number quickly, now damage done very well . Adrock will continue send negative until , break up with good news, numbers .... it's his job .
Shawn - you have today BIG SPEECH DIARRHEA .... you call everyone who is not agree with your negativity opinion - idiot or stupid . Q? - Who you are ? .... if you don't trust INNV , just go ..... your average price around 0.40c. + , its mean you still believe , even you want get out around this price. Never see person , who has stock and talking , talking , talking negativity ... are you feel better after your Speech Diarrhea... p.s. my average price 0.156c. , and many investors has low enter price ... last time I got in 0.08 -0.12c. and get out 0.51c. ... your problem you don't want buy more shares make it average down . WE TAKE IT RISK , BUT IT IS OUR RISK !!! Please Stop CRY . Be Blessed !!!
you two brother very happy with your negativity . Enjoy p.s. Do you really think anyone on this board listen your opinion ? ....its call time losers.
Adrock - increase posts , usually he drop one post daily , today is 7 already , look like he getting nervous with all his brothers here .........
OVIT - does not have nothing , nice try .... you cant compere with INNV , .....
,,DOGS BARKING , BUT CARAVAN GOES,, !!!
But what do i know !
100% AGREE !!! Headline Announcements coming soon:
1) Innovus Pharmaceuticals receives EU patents for Sensum+(R) and has signed exclusive agreements with several distributors to begin commercializing Sensum+(R) in this $ billion market opportunity.
2) Innovus Pharmaceuticals announces FDA ANDA approval for FlutiCare and announces plans to begin offering its popular brand over-the-counter starting in the second half of 2017.
3) Innovus Pharmaceuticals announces new distribution partnerships in several major EU markets for its best selling product Zestra, tapping into the $1billion market for FSD.
4) Innovus Pharmaceuticals announces approval for commercialization for Zestra Glide in the EU, paving the way for INNV to begin forming distribution partnerships to tap into the $1billion market opportunity for FSD. p.s. from Matthew YB.
More positive from YB... Absolutely agree!!! What seems to be lost in the noise is that this company continues to execute. All these approvals mean one thing and one thing only: FUTURE SALES! While some will argue that this is meaningless, I would argue that anytime the company gets approval to sell their product in market worth hundreds of millions of dollars it is a tremendous accomplishment which will lead to future sales growth. Let's not forget that this product is one of their top products in the US
hundreds orders 5000 shares , its MM game .....
INNV 52 Week Range 0.06 - 0.66c. and UP +90% from 52Week Low !!!
AMEN !!!
(seriously it hurts me but have lost hope.) sorry about your lost hope . Movie -action just started ... So keep your $$$$ in Bank of America CD ...
INNV start to move UP today .... watch and learn Androk !!!
Wednesday, 29 Mar 2017 12:07 PM Conclusion
The CEO of Innovus, Dr. Bassam Damaj, is trying to turnaround the company, registering new products in Europe and raising capital from investors. We cannot really say whether the company will succeed, but the company is giving the markets a clear sign that it’s working on a turnaround. Overall, we see INNV as an attractive turnaround play and at current levels, the upside is much greater than any downside
https://www.insiderfinancial.com/innovus-pharmaceuticals-inc-otcmkts-innv-a-prime-turnaround-play/120446/
(garbage news ) !!!??? TRUMP , what are you doing here ?
Sorry. but I taped usually ,,NICE OPINIOM OR RESEARCH ,, Its mean from someone , last one just not finished , ,, From YB. ,, still very good point from YB.
Team Long - After many hours of research, I believe I have cracked the code on WHO the FlutiCare ANDA original applicant and manufacturer is? I have been putting the pieces of the puzzle together and finally, it was right there in front of me. Team I am about 99% certain this IS the company the good Dr. Damaj partnered with to get his FlutiCare approved by the FDA. He wanted a company with a stellar record and major status to go head-to-head with GSK or Bayer in case they rattled their sabers to protect their billion dollar allergic rhinitis (nasal spray) market. He INSISTED at the time of the Novalere filing that THIS company has to be the ANDA applicant and the manufacturer when the OTC is approved by the FDA.
Do you guys want to know the name?
Now that I believe I know who the manufacturer is (a real power-house), I will be adding shares on Monday. I am not boasting; just sharing how confident I am FlutiCare will get approved. Actually, I am not even worried about FlutiCare; I am now focused on 2017 profitability and up-listing in 2018 so we can see some "real" growth in shareholder value . Team - As we know well, it is important for Innovus to hit the two immediate milestones in order for it to have a decent shot at up-listing. The first milestone is FlutiCare approval and the second material event is NOI profitability at the end of 2017. In my opinion, these are the two major events that we need which will help start the SP assent.
With respect to FlutiCare approval, Innvous needed a "heavyweight" pharma manufacturer to file for the ANDA so that it could have reasonable chance of FDA approval. Not that this is be-all/end-all, it just means the road to approval was being given better odds of success.
Here is how I deduced the name of the pharma company:
I have gone back and looked at several interviews Dr. Damaj gave since 2015. I was looking for any clues he may have shared. I was particularly interested in his October 2016 interview and looked at a couple of sections very carefully. In this interview, he said that he was very clear in his filing (with Novalere) that the ANDA application MUST be filed by this one particular company who was the holder of the (Fluticasone Propionate) Rx ANDA and also the manufacturer of the Rx. This was a huge clue and so I focused-in on this statement.
I then looked at some of the information/profile I had gathered previously about the original ANDA applicant. As I shared with you all last week in a posting, the original applicant is a major player with revenues of over $1 billion and well over 100 FDA approved products on the market and has manufacturing plants in the U.S. as well as overseas. I verified this information with IR so I knew we were on solid footing. While IR never gave me the name (they obviously can't) but did confirm that this major pharma company already had an FDA approved nasal spray on the market.
So I did some more digging:
I looked at all the Fluticasone Propionate (nasal spray applications) approved by the FDA since 2004. I wanted to look for a company that was the holder of the fluticasone propionate Rx ANDA and was also the manufacturer.
And that's when I came across ANDA # 076504 which was filed by West-Ward Pharmaceutical and approved May 14, 2004. I believe this was the "hint" Dr. Damaj shared in his 10/16 interview.
So team, my conclusion is that Dr. Damaj partnered with Hikma Pharmaceutical when he transacted with Novalere. Hikma is the parent company that will produce our FlutiCare through West-Ward which is a holly-owned subsidiary of Hikma based in the U.S. To me this is conclusive because last year, West-Ward Pharma partnered with Perrigo Company plc (a leading supplier of OTC products) to market and sell fluticasone propionate as an OTC product which was approved on 5/31/16.
Go and check-out Hikma Pharmaceutical and you will see how Dr. Damaj could have ties with this company given that this is company has deep roots in Jordan and Dubai. Hikma did about $1.3 billion in 2015 revenue and has manufacturing plants in the U.S. and many other countries and all are FDA approved.
Team - I may be wrong about this but at least we know that FlutiCare is in good hands if I am correct with my due diligence. If FlutiCare gets approved, NOI profitability will be inevitable followed by increased shareholder value followed by up-listing etc. Please remember Hikma got fluticasone propionate approved for Perrigo on 5/31/16 which means the FDA will probably approve their second fluticasone propionate (FlutiCare) by May 2017 or thereabouts. Just a hunch.
Nice opinion .......research.
AMERICANBULLS 3/24/2017 :INNV
INNOVUS PHARMACEUTICALS
Last Signal: BUY
Last Pattern: BULLISH HOMING PIGEON
Last Close:
0.1100
Change:
+0.0043
Percent change
+4.07%
Signal Update
Our system’s recommendation today is to BUY. The BULLISH HOMING PIGEON pattern finally received a confirmation because the prices crossed above the confirmation level which was at 0.1065, and our valid average buying price stands now at 0.1083. The previous SELL signal was issued on 03/07/2017, 17 days ago, when the stock price was 0.2794. Since then INNV has fallen by -61.24%.
Nice Try , but nobody listen to you , sorry ....
But I warned you didn't I?
What do I know......more than you!
All this negativity I call ,, DOGS BARKING , BUT CARAVAN GOES ,, long position total is 245K shares average 0.164c.
p.s. only green pea doesn't know what's mean 5000 ask multiple times .....
Agree . Thanks . Added 89K shares morning ...
Q -BIG ??? WHAT ARE YOU DOING HERE ? Try save our $$$ , its to late ........... talking, talking , talking .. negativity will bring in your life more Negativity !!!! p.s. will see who is who very soon .
INNV is def a personal enrichment scheme! Beware! Take your money and invest in something else!!!! you said . Q -BIG ??? WHAT ARE YOU DOING HERE ? WHY YOU NOT FOLLOW YOUR PREDICTION , JUST SELL AND GET OUT OF THIS SUPER NEGATIVE INVESTMENT.. p.s. anyway I add 90K shares more this morning ... Thanks
"Currently trading with a market cap of $20 million, INNV is a compelling story on the OTC Markets. Its current market cap does not reflect this year’s expected revenues of $15 million or the potential of FlutiCare. Even without FlutiCare, INNV expects to achieve profitability this year. This will go a long way in getting picked up by more investors and lead to an up-listing to Nasdaq. Overall, INNV looks poised for a banner year."
At $0.10 current price, this is a tremendous purchase. Those who will buy at these prices will be rewarded exponentially by the end of Q1 2018. The sequence of events will be as follows: First FlutiCare approval (by summer 2017), then followed by NOI profitability by end of 2017 and then a campaign to up-list to a higher exchange while drawing more institutional investors. In about 18 months, this under-valued company will make its mark in a big way. I have made-up my mind to stay with Messrs. Damaj, Hoffman and Berholz and see where they take us. There is an awful lot of experience, talent and integrity in this team. I am following strong fundamentals, a solid guidance for 2017 and a good management team. The terms of the recent offering were not so favorable, at least not for the short-term, but hey, the bad news is out of the way and is baked-in the current $0.10 price. We all knew Innovus needed $$ to market and sell FlutiCare or how else would they have a chance to compete with GSK. All they need is 5% to 6% of the $1 billion dollar rhinitis/allergy market. This is a very fair and achievable target if the ANDA is approved. Just thing what $50 to $60 million additional dollars will do for this company by 2018.
My advice for the longs is to ignore the noise and the distractions on this MB and just stick with your due diligence and with the fundamentals. Yahoo board...
I started on July 2016 with 80K shares 0.12c. in ... , when they run I sold average 0.44c. after they touch 0.66 c. now I keep on two acc# 156K average 0.19c. Started buy back from 0.306c. 0.183c. last part was 71k shares 0.12c. ... a lot negativity in this board , but its good ... have rule .don't listen ,, DOG BARKING , BUT CARAVAN GOES ,,
from all of yours link only the last one not open , first two above open ..
https://scontent-lax3-2.xx.fbcdn.net/v/t34.0-12/17410402_1305580169528958_251556180_n.jpg?oh=d6c99ed92f9a272b01373ed1148e615d&oe=58D455BD
https://scontent-lax3-2.xx.fbcdn.net/v/t34.0-12/17410402_1305580169528958_251556180_n.jpg?oh=d6c99ed92f9a272b01373ed1148e615d&oe=58D455BD
https://scontent-lax3-2.xx.fbcdn.net/v/t34.0-12/17440151_1305580202862288_1785526567_n.jpg?oh=cdb0f72331e631e0b72bf1f7d7f6d24f&oe=58D453F0
keep Dreaming ..................
,, Dog barking , but caravan goes ,, !!!